UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral-Naive Subjects

The Journal of infectious diseases, 2005-12, Vol.192 (11), p.1921-1930

2005

Volltextzugriff (PDF)

Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial

PloS one, 2014-05, Vol.9 (5), p.e96187

2014

Volltextzugriff (PDF)

Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

AIDS research and therapy, 2008-03, Vol.5 (1), p.5-5

2008

Volltextzugriff (PDF)

Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients

AIDS research and human retroviruses, 2010-04, Vol.26 (4), p.407-417

2010

Volltextzugriff (PDF)

Nevirapine absorbed well despite chronic diarrhea

AIDS research and human retroviruses, 2005-06, Vol.21 (6), p.597-597

Weinberg, Winkler G

2005

Volltextzugriff (PDF)

Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS

The New England journal of medicine, 1993-09, Vol.329 (12), p.828-833

1993

Volltextzugriff (PDF)

Invasive Infection Due to Apophysomyces elegans in Immunocompetent Hosts

Clinical infectious diseases, 1993-11, Vol.17 (5), p.881-884

1993

Volltextzugriff (PDF)

Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial: e96187

PloS one, 2014-05, Vol.9 (5)

2014

Volltextzugriff (PDF)

Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects. Commentary

The Journal of infectious diseases, 2005, Vol.192 (11), p.1921-1930

2005

Volltextzugriff (PDF)

Fosamprenavir or atazanavir once daily boosted with ritonavir 100mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

AIDS research and therapy, 2008, Vol.5 (1), p.5

2008

Volltextzugriff (PDF)

Tropical pyomyositis: delineation by gray scale ultrasound

The American journal of tropical medicine and hygiene, 1984-09, Vol.33 (5), p.930-932

1984

Volltextzugriff (PDF)

Oral Atovaquone Compared with Intravenous Pentamidine for Pneumocystis carinii Pneumonia in Patients with AIDS

Annals of internal medicine, 1994-08, Vol.121 (3), p.174

Dohn, Michael N.

1994

Volltextzugriff (PDF)

Safety and efficacy of teicoplanin for bone and joint infections: results of a community-based trial

Southern medical journal (Birmingham, Ala.), 1993-08, Vol.86 (8), p.891-897

Weinberg, W G

1993

Volltextzugriff (PDF)

Epidemiology of human rabies post-exposure prophylaxis at the US Naval Facility, Subic Bay, Philippines

American journal of public health (1971), 1985-12, Vol.75 (12), p.1440-1441

1985

Volltextzugriff (PDF)

E. COLI–FREE COOKOUTS

Scientific American, 2001-09, Vol.285 (3), p.13-13

WEINBERG, WINKLER G.

2001

Volltextzugriff (PDF)

Chlamydia trachomatis: an uncommon cause of cystourethritis in female dependents of military personnel

Military medicine, 1983-05, Vol.148 (5), p.453-454

1983

Volltextzugriff (PDF)

Medical advice for foreign travel

Military medicine, 1986-04, Vol.151 (4), p.211-220

1986

Volltextzugriff (PDF)

FIGHTING GERMS

Scientific American, 1998-07, Vol.279 (1), p.10-10

1998

Volltextzugriff (PDF)

Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients

Journal of acquired immune deficiency syndromes (1999), 2008-03, Vol.47 (3), p.384-390

2008

Volltextzugriff (PDF)

Atovaquone for Salvage Treatment and Suppression of Toxoplasmic Encephalitis in Patients with AIDS

Clinical infectious diseases, 1997-03, Vol.24 (3), p.422-429

1997

Volltextzugriff (PDF)

Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)

HIV medicine, 2009-02, Vol.10 (2), p.116-124

2009

Volltextzugriff (PDF)

Patient demographics and implant survival at uncovering: Dental Implant Clinical Research Group Interim Report No. 6

Implant dentistry, 1994, Vol.3 (4), p.247-251

1994

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(20)
magazinearticle
(2)

Sprache

Englisch
(22)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Early Virologic Nonresponse to Tenofovir, Abacavir, and Lamivudine in HIV-Infected Antiretroviral-Naive Subjects

Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial

Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

Impact of low abundance HIV variants on response to ritonavir-boosted atazanavir or fosamprenavir given once daily with tenofovir/emtricitabine in antiretroviral-naive HIV-infected patients

Nevirapine absorbed well despite chronic diarrhea

Two Controlled Trials of Rifabutin Prophylaxis against Mycobacterium avium Complex Infection in AIDS

Invasive Infection Due to Apophysomyces elegans in Immunocompetent Hosts

Simplification to Abacavir/Lamivudine + Atazanavir Maintains Viral Suppression and Improves Bone and Renal Biomarkers in ASSURE, a Randomized, Open Label, Non-Inferiority Trial: e96187

Early virologic nonresponse to tenofovir, abacavir, and lamivudine in HIV-infected antiretroviral-naive subjects. Commentary

Fosamprenavir or atazanavir once daily boosted with ritonavir 100mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT

Tropical pyomyositis: delineation by gray scale ultrasound

Oral Atovaquone Compared with Intravenous Pentamidine for Pneumocystis carinii Pneumonia in Patients with AIDS

Safety and efficacy of teicoplanin for bone and joint infections: results of a community-based trial

Epidemiology of human rabies post-exposure prophylaxis at the US Naval Facility, Subic Bay, Philippines

E. COLI–FREE COOKOUTS

Chlamydia trachomatis: an uncommon cause of cystourethritis in female dependents of military personnel

Medical advice for foreign travel

FIGHTING GERMS

Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients

Atovaquone for Salvage Treatment and Suppression of Toxoplasmic Encephalitis in Patients with AIDS

Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV‐infected, therapy‐naïve patients: results of the EPIC study (CCR100136)

Patient demographics and implant survival at uncovering: Dental Implant Clinical Research Group Interim Report No. 6

Suchergebnisse filtern